MX2021005165A - Aerosolisable formulation. - Google Patents

Aerosolisable formulation.

Info

Publication number
MX2021005165A
MX2021005165A MX2021005165A MX2021005165A MX2021005165A MX 2021005165 A MX2021005165 A MX 2021005165A MX 2021005165 A MX2021005165 A MX 2021005165A MX 2021005165 A MX2021005165 A MX 2021005165A MX 2021005165 A MX2021005165 A MX 2021005165A
Authority
MX
Mexico
Prior art keywords
aerosolisable formulation
aerosolisable
formulation
nicotine
amount
Prior art date
Application number
MX2021005165A
Other languages
Spanish (es)
Inventor
Ross Cabot
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of MX2021005165A publication Critical patent/MX2021005165A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/05—Devices without heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)

Abstract

There is provided an aerosolisable formulation comprising (i) water in an amount of at least 5 0 wt.% based on the aerosolisable formulation; and (ii) nicotine; wherein the nicotine is present in an amount of no greater than 1wt.% based on the aerosolisable formulation.
MX2021005165A 2018-11-01 2019-10-31 Aerosolisable formulation. MX2021005165A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1817859.0A GB201817859D0 (en) 2018-11-01 2018-11-01 Aerosolisable formulation
PCT/GB2019/053095 WO2020089640A1 (en) 2018-11-01 2019-10-31 Aerosolisable formulation

Publications (1)

Publication Number Publication Date
MX2021005165A true MX2021005165A (en) 2021-07-15

Family

ID=64655549

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005165A MX2021005165A (en) 2018-11-01 2019-10-31 Aerosolisable formulation.

Country Status (13)

Country Link
US (1) US20210386111A1 (en)
EP (1) EP3873248A1 (en)
JP (2) JP2022506068A (en)
KR (1) KR102684583B1 (en)
CN (1) CN113163842A (en)
AU (1) AU2019373768B2 (en)
BR (1) BR112021008571A2 (en)
CA (1) CA3118060A1 (en)
GB (1) GB201817859D0 (en)
IL (1) IL282589B1 (en)
MX (1) MX2021005165A (en)
UA (1) UA127723C2 (en)
WO (1) WO2020089640A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
GB202013489D0 (en) 2020-08-27 2020-10-14 Nicoventures Holdings Ltd Consumable
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
IT202100005027A1 (en) * 2021-03-04 2022-09-04 Ape8 S R L INHALATION LIQUID COMPOSITION FOR ELECTRONIC CIGARETTES

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0462094U (en) * 1990-10-09 1992-05-27
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (en) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
GB0918129D0 (en) * 2009-10-16 2009-12-02 British American Tobacco Co Control of puff profile
EP2993999B1 (en) * 2013-05-06 2021-01-27 Juul Labs, Inc. Nicotine salt formulations for electronic cigarettes and method of delivering nicotine
PL3111784T3 (en) * 2014-02-26 2019-04-30 Japan Tobacco Inc Extraction method of flavor constituent and manufacturing method of composition element of favorite item
TWI664918B (en) 2014-05-21 2019-07-11 瑞士商菲利浦莫里斯製品股份有限公司 Inductively heatable tobacco product
GB201413835D0 (en) * 2014-08-05 2014-09-17 Nicoventures Holdings Ltd Electronic vapour provision system
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
US20160198759A1 (en) * 2015-01-13 2016-07-14 Zip Llc E-cigarette or vaping fluid
US20160345621A1 (en) * 2015-06-01 2016-12-01 San Li Pre-vapor formulation of an electronic vaping device and/or methods of manufacturing the same
DE102015117811A1 (en) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhaler and active ingredient-containing preparation for an inhaler
US20170172204A1 (en) * 2015-12-18 2017-06-22 Altria Client Services Llc Strength enhancers and method of achieving strength enhancement in an electronic vapor device
US20170325494A1 (en) * 2016-05-16 2017-11-16 Lunatech, Llc Liquid composition containing nicotine from non-tobacco source for use with electronic vaporizing devices
US20180199618A1 (en) * 2016-09-27 2018-07-19 Bond Street Manufacturing Llc Vaporizable Tobacco Wax Compositions and Container thereof
GB2569940B (en) * 2017-11-01 2022-10-19 Nicoventures Trading Ltd Aerosolisable formulation
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation

Also Published As

Publication number Publication date
WO2020089640A1 (en) 2020-05-07
JP2022506068A (en) 2022-01-17
UA127723C2 (en) 2023-12-13
EP3873248A1 (en) 2021-09-08
AU2019373768B2 (en) 2022-12-01
BR112021008571A2 (en) 2021-08-03
CN113163842A (en) 2021-07-23
CA3118060A1 (en) 2020-05-07
KR102684583B1 (en) 2024-07-11
AU2019373768A1 (en) 2021-05-27
US20210386111A1 (en) 2021-12-16
KR20210074308A (en) 2021-06-21
JP2023101020A (en) 2023-07-19
IL282589B1 (en) 2024-08-01
IL282589A (en) 2021-06-30
GB201817859D0 (en) 2018-12-19

Similar Documents

Publication Publication Date Title
MX2021005165A (en) Aerosolisable formulation.
MX2021005163A (en) Aerosolisable formulation.
MX2021005120A (en) Aerosolised formulation.
MX2021007416A (en) Foaming agent compositions containing 1,2,2-trifluoro-1-trifluoro methylcyclobutane, and methods of foaming.
MX369415B (en) Concentrated personal cleansing compositions.
MX2021005167A (en) Gel and crystalline powder.
MX2021005164A (en) Aerosolisable formulation.
MX2022001061A (en) Interleukin-2 agents and uses thereof.
AU2018263859A1 (en) Alcohol containing non-antimicrobial cleansing composition
MX2019013605A (en) Homogenised botanical material comprising a basic ph modifier.
MX2020005942A (en) Oral thin film with high active agent loading.
MY192577A (en) Ophthalmic solution comprising epinastine
CR20200275A (en) Hydroxyisoxazolines and derivatives thereof
SG10201901275PA (en) Storage device and server including the storage device
MX2017013534A (en) Concentrated personal cleansing compositions and uses.
EP4275497A3 (en) Synergistically effective herbicide composition comprising pelargonic acid and flazasulfuron
WO2019017735A3 (en) Water drop solid uv-blocking cosmetic composition
MX2018003086A (en) Composition having reduced residue.
EP4275761A3 (en) Alkaline phosphatase agents for treatment of radiation disorders
MY183391A (en) Refrigerant pack
MX2021000719A (en) Fecal microbiota composition, for use in reducing treatment-induced inflammation.
MX2021005119A (en) Aerosolised formulation.
EP4269549A3 (en) Skin cleansing compositions
NZ763603A (en) Flavoured vaporisable formulation
MX364736B (en) Anti-calculus oral compositions.